Thu 13 Aug 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
2025-12-18
SFDA Approves the Registration of “Qfitlia” for Hemophilia A or B
The Saudi Food and Drug Authority (SFDA) has approved the registration of Qfitlia (Fitusiran) for routine prophylaxis to prevent or reduce the...
2025-12-11
SFDA to Organize Generic Drug Conference to Empower Local Pharmaceutical Manufacturing on December 30
The Saudi Food and Drug Authority (SFDA) is organizing a Generic Drug Conference, titled "Empowering Local Pharmaceutical Manufacturing: The Future of...
2025-12-01
Global Leadership for Increasing Patient Accessibility, SFDA Expands Lojuxta Indication to Include Treatment of Children with Homozygous Familial Hypercholesterolemia (HoFH)
The Saudi Food and Drug Authority (SFDA) announced its approval of a new medical claim for Lojuxta (lomitapide), allowing its use to treat children...
2025-11-20
SFDA Organizes Scientific Forum on Antimicrobial Resistance Awareness
On Wednesday, November 19, the Saudi Food and Drug Authority (SFDA), in cooperation with the Waey Association for Community Health, held a scientific...
2025-11-11
The SFDA and the Cultural Houses Organize Workshop on Safe Antibiotic Use Next Week
The Saudi Food and Drug Authority (SFDA), in cooperation with the Cultural Houses “Al-Taawun Public Library”, one of initiatives under the Libraries...
2025-11-10
SFDA Approves the Registration of “Pemazyre” for the Treatment of Bile Duct Cancer in Adults
The Saudi Food and Drug Authority (SFDA) has approved the registration of Pemazyre (Pemigatinib) as a monotherapy for adults with locally advanced or...Last update date: 13/08/2026 at 12:55 PM Saudi Arabia time
No feedback has been submitted for this page yet.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.